X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2121) 2121
Publication (214) 214
Book Review (40) 40
Book Chapter (8) 8
Dissertation (5) 5
Conference Proceeding (4) 4
Magazine Article (3) 3
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anastrozole (1909) 1909
humans (1446) 1446
female (1348) 1348
oncology (1169) 1169
breast neoplasms - drug therapy (1131) 1131
tamoxifen (1115) 1115
breast cancer (1079) 1079
postmenopausal women (1054) 1054
index medicus (906) 906
letrozole (763) 763
aromatase inhibitors (715) 715
middle aged (621) 621
antineoplastic agents, hormonal - therapeutic use (525) 525
aged (520) 520
endocrine therapy (500) 500
randomized-trial (486) 486
aromatase inhibitors - therapeutic use (477) 477
postmenopause (445) 445
nitriles - therapeutic use (435) 435
triazoles - therapeutic use (434) 434
breast neoplasms - pathology (429) 429
cancer (408) 408
tamoxifen - therapeutic use (391) 391
exemestane (377) 377
treatment outcome (355) 355
aromatase inhibitor (332) 332
adult (319) 319
chemotherapy, adjuvant (314) 314
estrogen (306) 306
care and treatment (295) 295
therapy (274) 274
double-blind (270) 270
women (264) 264
aged, 80 and over (255) 255
first-line therapy (253) 253
medicine & public health (249) 249
chemotherapy (247) 247
fulvestrant (216) 216
trial (215) 215
breast neoplasms - metabolism (209) 209
aromatase inhibitors - adverse effects (208) 208
obstetrics & gynecology (205) 205
nitriles - administration & dosage (203) 203
triazoles - administration & dosage (203) 203
adjuvant treatment (199) 199
research (187) 187
analysis (184) 184
phase-iii (184) 184
megestrol-acetate (180) 180
drug therapy (175) 175
pharmacology & pharmacy (174) 174
receptors, estrogen - metabolism (174) 174
antineoplastic agents, hormonal - adverse effects (171) 171
nitriles - adverse effects (171) 171
antineoplastic agents - therapeutic use (168) 168
combination (168) 168
triazoles - adverse effects (168) 168
health aspects (167) 167
tamoxifen therapy (166) 166
aromatase (164) 164
disease-free survival (163) 163
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
randomized controlled trials as topic (156) 156
antineoplastic agents, hormonal - administration & dosage (148) 148
clinical trials as topic (147) 147
endocrinology & metabolism (147) 147
tamoxifen - administration & dosage (146) 146
clinical trials (144) 144
estradiol - analogs & derivatives (143) 143
breast neoplasms - mortality (142) 142
neoplasms, hormone-dependent - drug therapy (140) 140
aromatase inhibitors - administration & dosage (138) 138
hematology, oncology and palliative medicine (138) 138
neoplasm staging (136) 136
prognosis (134) 134
androstadienes - therapeutic use (124) 124
estrogen-receptor (122) 122
menopause (122) 122
animals (120) 120
expression (120) 120
risk factors (119) 119
efficacy (117) 117
metastasis (116) 116
breast neoplasms - surgery (112) 112
carcinoma (112) 112
neoadjuvant therapy (112) 112
survival (112) 112
adjuvant therapy (111) 111
male (108) 108
nitriles - pharmacology (107) 107
triazoles - pharmacology (107) 107
prevention (106) 106
retrospective studies (104) 104
advanced breast-cancer (103) 103
enzyme inhibitors - therapeutic use (103) 103
surgery (102) 102
article (100) 100
risk (96) 96
double-blind method (95) 95
aromatase inhibitors - pharmacology (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2068) 2068
German (23) 23
French (22) 22
Spanish (12) 12
Japanese (3) 3
Korean (3) 3
Chinese (2) 2
Turkish (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast Cancer Research and Treatment, ISSN 0167-6806, 6/2018, Volume 169, Issue 3, pp. 537 - 548
Journal Article
Japanese Journal of Cancer and Chemotherapy, ISSN 0385-0684, 06/2018, Volume 45, Issue 6, pp. 965 - 968
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2019, Volume 380, Issue 23, pp. 2282 - 2282
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer (N Engl J Med 2019;380:1226-1234). In the list of authors (page 1226), Dr.... 
Breast cancer | Metastasis | Anastrozole | Survival | Fulvestrant | Metastases
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2019, Volume 380, Issue 13, pp. 1226 - 1234
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2017, Volume 35, Issue 2, pp. 261 - 261
Journal Article
JAMA OPHTHALMOLOGY, ISSN 2168-6165, 05/2019, Volume 137, Issue 5, pp. 581 - 582
This case report describes a 69-year-old woman with a history of hypertension and breast cancer who presented with blurry vision in both eyes. 
OPHTHALMOLOGY | Breast cancer | Retinopathy | Ophthalmology | Anastrozole
Journal Article
Annals of Oncology, ISSN 0923-7534, 12/2018, Volume 29, Issue 12, pp. 2274 - 2278
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2017, Volume 35, Issue 23, pp. 2718 - 2719
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 09/2005, Volume 97, Issue 17, pp. 1262 - 1271
Background. Most recurrences in women with breast cancer receiving 5 years of adjuvant tamoxifen occur after 5 years. The MA.17 trial, which was designed to... 
CLINICAL-PHARMACOLOGY | ONCOLOGY | ESTROGEN | RECURRENCE | MECHANISMS | QUALITY-OF-LIFE | POSTMENOPAUSAL WOMEN | COMBINATION | AROMATASE INHIBITORS | AMERICAN-SOCIETY | ANASTROZOLE
Journal Article
European Journal of Cancer Care, ISSN 0961-5423, 03/2018, Volume 27, Issue 2, pp. e12834 - n/a
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 12/2015, Volume 13, Issue 12, pp. 1475 - 1485
These NCCN Guideline Insights highlight the important updates to the systemic therapy recommendations in the 2016 NCCN Guidelines for Breast Cancer. In the... 
OVARIAN SUPPRESSION | 1ST-LINE TREATMENT | PERTUZUMAB PLUS TRASTUZUMAB | ONCOLOGY | PREOPERATIVE THERAPY | DOUBLE-BLIND | LETROZOLE | POSTMENOPAUSAL WOMEN | CHEMOTHERAPY | NEOADJUVANT | ANASTROZOLE
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2016, Volume 34, Issue 16, pp. 1959 - 1960
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2000, Volume 18, Issue 7, pp. 1399 - 1411
Purpose: This phase ill, double-blind, randomized, multicenter study evaluated the efficacy, pharmacodynamics, and safety of the oral aromatase inactivator... 
ONCOLOGY | HORMONAL TREATMENT | STEROIDAL AROMATASE INHIBITOR | AMINOGLUTETHIMIDE | ENDOCRINE | ANASTROZOLE
Journal Article
LANCET ONCOLOGY, ISSN 1470-2045, 09/2019, Volume 20, Issue 9, pp. 1226 - 1238
Background Endocrine therapy-based neoadjuvant treatment for luminal breast cancer allows efficient testing of new combinations before surgery. The activation... 
NEOADJUVANT CHEMOTHERAPY | EFFICACY | ONCOLOGY | CLINICAL ONCOLOGY/COLLEGE | RECOMMENDATIONS | FULVESTRANT | ENDOCRINE THERAPY | INHIBITOR | AMERICAN SOCIETY | ANASTROZOLE | PREDICTION
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.